Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

ClinicalTrials.gov ID: NCT06491914

Public ClinicalTrials.gov record NCT06491914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b Single-Arm Study of Aflibercept 8 mg in Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is researching aflibercept high dose (HD), referred to as "study drug", with an experimental dosing regimen. The study is focused on participants with nAMD and DME that have been previously treated with anti-vascular endothelial growth factor (anti-VEGF) medications. The aim of the study is to see how safe and effective aflibercept HD injections are when given as frequently as every 4 weeks. The study is also looking at what side effects may happen from taking the study drug.

Study identification

NCT ID
NCT06491914
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
1,126 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2024 (Actual)
Primary completion
Aug 26, 2025 (Actual)
Completion
Jan 7, 2027 (Estimated)
Last update posted
Sep 18, 2026

2024 – 2027

United States locations

U.S. sites
53
U.S. states
22
U.S. cities
51
Facility City State ZIP Site status
Win Retina - Arcadia Arcadia California 91006 —
California Retina Consultants Bakersfield California 93309 —
Retina Specialists of Beverly Hills Beverly Hills California 90212 —
Salehi Retina Institute dba Retina Associates of Southern California Huntington Beach California 92647 —
South Coast Retina Center Long Beach California 90807 —
California Eye Specialists Medical Group, Inc. Pasadena California 91107 —
Retina Consultants of Southern California Redlands California 92374 —
Vrmg Inc Sacramento California 95825 —
Retina Consultants of Southern Colorado Colorado Springs Colorado 80909 —
Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute Longmont Colorado 80503 —
Retina Group of New England Waterford Connecticut 06385 —
Advanced Research, LLC Deerfield Beach Florida 33064 —
Florida Retina Institute - Jacksonville Jacksonville Florida 32216 —
Florida Retina Consultants Lakeland Florida 33805 —
Florida Retina Institute - Orlando Orlando Florida 32806 —
Retina Speciality Institute - Pensacola, Florida Pensacola Florida 32503 —
Eye Associates of Pinellas Pinellas Park Florida 33782 —
Retina Vitreous Associates of Florida Saint Petersburg St. Petersburg Florida 33711 —
Retina Vitreous Associates of Florida Tampa Florida 33617 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Georgia Retina Marietta Georgia 30060 —
Retina Consultants of Hawaii, Inc. ‘Aiea Hawaii 96701 —
University Retina and Macula Associates PC - Lemont Lemont Illinois 60439 —
Illinois Retina Associates Oak Park Illinois 60304 —
Cumberland Valley Retina Consultants-Ophthalmology Hagerstown Maryland 21740 —
Mid Atlantic Retina Specialists Hagerstown Hagerstown Maryland 21740 —
Opthalmic Consultants of Boston Boston Massachusetts 02114 —
Retina Consultants of Minnesota Edina Minnesota 55435 —
Deep Blue Retina Clinical Research PLLC Southaven Mississippi 38671 —
Vision Research Center Eye Associates of New Mexico Albuquerque New Mexico 87109 —
Vitreoretinal Consultants of NY - Westbury Westbury New York 11590 —
North Carolina Retina Associates Wake Forest North Carolina 27587 —
Retina Associates of Cleveland - Beachwood Beachwood Ohio 44122 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Tulsa Retina Consultants Tulsa Oklahoma 74114 —
EyeHealth Northwest Portland Oregon 97225 —
Mid Atlantic Retina Bethlehem Pennsylvania 18017 —
Sewickley Eye Group Sewickley Pennsylvania 15143 —
Charleston Neuroscience Institute LLC Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Tennessee Retina, PC Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Austin Retina Associates Austin Texas 78705 —
Retina Consultants of Texas Beaumont Texas 77707 —
Retina Consultants of Texas - Houston Bellaire Texas 77401 —
Texas Retina Associates - Dallas Dallas Texas 75231 —
Southwest Retina Consultants El Paso Texas 79902 —
Retina Consultants of Texas Katy Texas 77494 —
Austin Retina Associates Round Rock Texas 78681 —
Retina Consultants of Texas San Antonio Texas 78240 —
Retina Consultants of Texas Brown Retina Institute San Antonio Texas 78251 —
Retina Consultants Texas The Woodlands Texas 77384 —
Pacific Northwest Retina Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06491914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06491914 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →